BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PharSafer® - Global Clinical and Post Marketing Drug Safety - ECPv6.17.5//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PharSafer® - Global Clinical and Post Marketing Drug Safety
X-ORIGINAL-URL:https://pharsafer.com
X-WR-CALDESC:Events for PharSafer® - Global Clinical and Post Marketing Drug Safety
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260609
DTEND;VALUE=DATE:20260612
DTSTAMP:20260528T113945Z
CREATED:20260527T163518Z
LAST-MODIFIED:20260528T113945Z
UID:3106-1780963200-1781222399@pharsafer.com
SUMMARY:World Orphan Drug Congress USA 2026
DESCRIPTION:World Orphan Drug Congress USA 2026 \nDate: June 9th-11th\, 2026 \nLocation: Boston\, USA \nPharSafer® is pleased to confirm our participation as a Gold Sponsor at the World Orphan Drug Congress USA 2026\, one of the leading global events focused on orphan drugs\, rare disease development\, regulatory strategy\, and patient-centred innovation. \nBringing together pharmaceutical companies\, biotech organisations\, regulators\, patient advocacy groups\, and industry experts from across the rare disease landscape\, WODC USA provides an important platform for discussing the evolving challenges surrounding orphan-drug development and long-term patient safety. ​ \nExclusive Speaker Session \nJoin Dr. Graeme Ladds\, CEO of PharSafer®\, for an insightful speaker session within the Clinical Development & Regulatory track: \n\n“What Makes Orphan Drug Pharmacovigilance Different? Real-World Challenges and Practical Solutions” \n\nPharmacovigilance for orphan and ultra-orphan therapies carries the same regulatory expectations as any other product – if not more – yet the path to achieving compliant\, sustainable safety oversight is often significantly more challenging. \nIn this session\, Dr. Ladds will explore the practical realities of pharmacovigilance in rare disease settings\, including how limited clinical exposure\, fragmented real-world evidence\, dispersed patient populations\, and complex disease backgrounds can make safety interpretation disproportionately difficult. \nKey discussion areas will include: \n\nWhy traditional pharmacovigilance approaches often struggle in orphan-drug settings\nThe challenges created by limited datasets\, translation barriers\, and complex disease profiles\nPractical\, proportionate PV approaches that support compliance without overwhelming smaller teams\nBuilding credible\, defensible safety oversight where every individual case can significantly influence patient understanding and programme confidence\nThe wider role of pharmacovigilance in supporting regulatory confidence\, programme sustainability\, and long-term development success\n\nIdeal for: Pharmacovigilance leaders\, regulatory professionals\, clinical development teams\, biotech innovators\, medical affairs professionals\, and organisations involved in orphan and ultra-orphan drug development. \nAttendees will leave with a deeper understanding of the operational and strategic challenges unique to orphan-drug pharmacovigilance\, alongside practical insight into designing sustainable safety frameworks for low-data environments. \n​Connect with PharSafer® in Boston \nOur senior team will be available throughout the event and would welcome the opportunity to discuss your organisation’s challenges and explore tailored support across: \n\nClinical & Post-Marketing Pharmacovigilance\nRare Disease & Orphan Drug Safety Strategy\nGlobal Regulatory Strategy & Risk Management Planning\nAuditing\, Training & Inspection Readiness\nMedical Affairs & Safety Communication\nSafety Automation & Workflow Innovation with RAPTAR®​\n\nSchedule a Meeting \nTo ensure dedicated time with our team during the event\, we encourage you to schedule your meeting with us in advance. \nWe look forward to connecting with industry colleagues and partners in Boston for what promises to be another valuable and insightful event. \nNote: For more information about the event\, please visit: World Orphan Drug Congress 2026.
URL:https://pharsafer.com/event/world-orphan-drug-congress-usa-2026/
LOCATION:Boston Convention & Exhibition Center\, 415 Summer Street\, Boston\, MA\, 02210\, United States
CATEGORIES:Business Meeting
ATTACH;FMTTYPE=image/png:https://pharsafer.com/wp-content/uploads/2026/05/WODC.png
ORGANIZER;CN="Terrapinn - WODC US":MAILTO:enquiry.usa@terrapinn.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260622
DTEND;VALUE=DATE:20260626
DTSTAMP:20260528T111535Z
CREATED:20260528T105705Z
LAST-MODIFIED:20260528T111535Z
UID:3128-1782086400-1782431999@pharsafer.com
SUMMARY:BIO International Convention 2026
DESCRIPTION:BIO International Convention 2026 \nDate: June 22nd-25th\, 2026 \nLocation: San Diego\, California\, USA \nPharSafer® is delighted to confirm our participation in the BIO International Convention 2026\, the world’s largest and most comprehensive biotechnology event\, bringing together global leaders across biotech\, pharmaceutical\, regulatory\, investment\, and innovation sectors. \nVisit PharSafer at Booth #5554 \nOur team will be available throughout the event and welcomes the opportunity to discuss your organisation’s challenges and explore tailored solutions across: \n\nClinical & Post-Marketing Pharmacovigilance\nGlobal Regulatory Strategy & Risk Management\nAuditing\, Inspection Readiness & Quality Support\nMedical Affairs & Medical Information Services\nPharmacovigilance Automation & Innovation via RAPTAR®\nSupport for Rare Disease\, Biologics & Advanced Therapies\n\nAs BIO 2026 continues to place increasing emphasis on partnering and pre-arranged meetings\, PharSafer® will also be actively engaging through the BIO Partnering platform throughout the event. \nWhether you are an emerging biotech preparing for clinical progression\, a growing pharmaceutical company seeking scalable global safety support\, or an established organisation exploring operational efficiencies and innovation\, our team would be pleased to connect. \nWant to Schedule a Meeting with PharSafer?  \nTo ensure dedicated one-to-one time with our team during BIO 2026\, we encourage attendees to arrange meetings in advance via the BIO Partnering platform or by contacting us directly ahead of the event. \nSchedule a meeting with PharSafer® to discuss your organisation’s requirements and discover how our global expertise\, regulatory insight\, and innovation-led approach can support your development and commercialisation objectives. \nWe look forward to connecting with you in San Diego for another exciting and impactful BIO International Convention.
URL:https://pharsafer.com/event/bio-international-convention-2026/
LOCATION:San Diego Convention Center\, 111 Harbor Dr\, San Diego\, CA\, 92101\, United States
CATEGORIES:Business Meeting
ATTACH;FMTTYPE=image/png:https://pharsafer.com/wp-content/uploads/2026/05/BIO-International.png
ORGANIZER;CN="BIO US":MAILTO:CustomerCare@bio.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260624
DTEND;VALUE=DATE:20260626
DTSTAMP:20260528T114311Z
CREATED:20260528T114311Z
LAST-MODIFIED:20260528T114311Z
UID:3135-1782259200-1782431999@pharsafer.com
SUMMARY:Drug Safety Symposium India 2026
DESCRIPTION:BIO International Convention 2026 \nDate: 24th–25th June 2026 \nLocation: Mumbai\, India \nPharSafer® is pleased to confirm our participation as a Gold Partner at the 6th Edition Drug Safety Symposium India 2026 (DSS India)\, one of the region’s leading events dedicated to modern pharmacovigilance\, patient safety\, regulatory strategy\, and drug safety operations. \nBringing together senior pharmacovigilance\, regulatory\, quality\, and clinical leaders from across the pharmaceutical industry\, DSS India provides an important platform for discussing the evolving operational and compliance challenges shaping global patient safety today. \nExclusive Speaker Session \nJoin Dr. Graeme Ladds\, CEO of PharSafer®\, for a thought-provoking session: \n“Patient Safety Under Pressure – Are We Still Waiting for the Balloon to Pop?” \nModern pharmacovigilance was built on the lessons learned from some of the industry’s biggest patient safety failures. Since then\, regulation\, oversight\, and safety systems have evolved dramatically – but so has the complexity surrounding them. \nToday’s PV environments are under constant pressure from growing case volumes\, fragmented global processes\, increasing regulatory expectations\, outsourcing models\, and rising operational burden. More data does not always mean better oversight – and in many organisations\, the pressure points are becoming harder to ignore. \nThis session will explore whether modern pharmacovigilance is genuinely reducing risk\, or whether new operational pressures are quietly building beneath the surface. Discussions will cover the realities affecting today’s safety teams\, including aggregate reporting\, data consistency\, medical interpretation\, inspection readiness\, and the evolving role of automation and AI within patient safety operations. \nUsing the concept of a “balloon under pressure”\, the session will challenge whether current pharmacovigilance models are truly sustainable long term – or simply delaying the next burst. \nMeet the PharSafer Team in Mumbai \nOur team will be available throughout DSS India 2026 to discuss the growing operational pressures facing modern pharmacovigilance environments and how organisations can build more scalable\, sustainable\, and inspection-ready safety operations. \nAreas of discussion include: \n\nClinical & Post-Marketing Pharmacovigilance\nAggregate Reporting & Medical Review\nGlobal Regulatory Strategy & Compliance\nInspection Readiness & Quality Oversight\nOperational Scalability & Outsourcing Models\nPharmacovigilance Automation & Workflow Optimisation\nRAPTAR® Safety Automation Solutions\n\nWhy Meet with PharSafer? \nAs a global CRO specialising in pharmacovigilance\, regulatory strategy\, medical services\, and safety technology\, PharSafer supports organisations across the full product lifecycle – from early clinical development through to post-marketing surveillance. \nWith increasing operational complexity across modern safety environments\, our focus remains on helping organisations improve consistency\, strengthen oversight\, reduce operational burden\, and maintain sustainable compliance without compromising patient safety. \nSchedule a Meeting \nIf you are attending DSS India 2026 and would like to discuss your organisation’s pharmacovigilance challenges\, operational goals\, or regulatory strategy\, we welcome the opportunity to connect with you in Mumbai. \nTo arrange a meeting with the PharSafer team\, please contact us directly or schedule your meeting with us in advance. \nWe look forward to meeting you at DSS India 2026.
URL:https://pharsafer.com/event/drug-safety-symposium-india-2026/
LOCATION:Courtyard by Marriott Mumbai International Airport\, CTS 215\, Andheri - Kurla Rd\, Mumbai\, Maharashtra\, 400093\, India
CATEGORIES:Business Meeting
ATTACH;FMTTYPE=image/png:https://pharsafer.com/wp-content/uploads/2026/05/Drug-Safety-Symposium.png
ORGANIZER;CN="Eminence Group Ventures":MAILTO:suryansh@eminencemedia.in
END:VEVENT
END:VCALENDAR